Written Question · S1W-03393 · Session 1
What its policy is on the use of beta interferon in the treatment of multiple sclerosis.
The question
To ask the Scottish Executive what its policy is on the use of beta interferon in the treatment of multiple sclerosis.
The answer
In 1995, guidance about new drugs for Multiple Sclerosis and clinical advice from the Scottish Medical Advisory Committee was issued to all Health Boards. The guidance asked Health Boards, in consultation with other key interests, to develop and implement local arrangements to manage the entry of these drugs into the NHS.The guidance remains extant and its implementation is a matter for each Health Board.
In the Official Report
No contribution in the Official Report cites S1W-03393 by reference.